Investor relations

Maintaining strong and transparent investor relations

We are focused on increasing our sales in contract manufacturing, exports, tender and institutional business in the domestic market. Our investment in research and development has been continued to meet the challenges of unmet medical needs.

While optimising profitability may be one measurement of our success, we recognize that responsible growth is also important. We are committed to providing quality, cost effective pharmaceutical solutions with significant emphasis on protecting the environment, occupational safety and health, and improving the lives of people.

At Ahlcon, a large part of its commitment to caring for life comprises its commitment to think and make a difference beyond the world of business into the world of the underprivileged and needy. Ahlcon recognises the importance of responsibility towards society and has constantly endeavored and embarked on spreading awareness about social responsibility.

Download Ahlcon's Investor Reports

Investor information

Contact Investor Relations at Ahlcon